Skip to main navigation Skip to search Skip to main content

Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments (Scientific Reports, (2023), 13, 1, (13912), 10.1038/s41598-023-40277-4)

  • Stephen Findlay‑Wilson
  • , Linda Easterbrook
  • , Sandra Smith
  • , Neville Pope
  • , Matthew Aldridge
  • , Gareth Humphries
  • , Holger Schuhmann
  • , Didier Ngabo
  • , Emma Rayner
  • , Ashley Otter
  • , Thomas Coleman
  • , Bethany Hicks
  • , Rachel Halkerston
  • , Kostis Apostolakis
  • , Stephen Taylor
  • , Susan Fotheringham
  • , Amanda Horton
  • , Irene CanoCejas
  • , Matthew Wand
  • , Julia A. Tree
  • Mark Sutton, Victoria Graham, Roger Hewson, Stuart Dowall*
*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Correction to: Scientific Reports, published online 25 August 2023 The original version of this Article contained errors in Table 2, where the data in the columns ‘Purified antibody’ and ‘Affinity-purified antibody’ was interchanged for the Antigen ‘RBD’. The correct and incorrect data appears below. Incorrect: (Table presented.) Purified antibody Affinity-purified antibody RBD 1194 9295 1699 8669 2535 17,871 2952 15,735 Correct: (Table presented.) Purified antibody Affinity-purified antibody RBD 9295 1194 8669 1699 17,871 2535 15,735 2952 The original Article has been corrected.

Original languageEnglish
Article number15419
JournalScientific Reports
Volume13
Issue number1
DOIs
Publication statusPublished - Dec 2023

Bibliographical note

Publisher Copyright:
© 2023, Springer Nature Limited.

Fingerprint

Dive into the research topics of 'Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments (Scientific Reports, (2023), 13, 1, (13912), 10.1038/s41598-023-40277-4)'. Together they form a unique fingerprint.

Cite this